1 / 132

WBC Pathology: Gen. Classification

WBC Pathology: Gen. Classification. Leukopenia a. ineffective granulopoesis suppression of stem cells – aplastic An, drugs ineffective maturation - B12 def Congenital- Kostmann Syndrome b. increased destruction Ig -mediated injury peripheral utilization

jerold
Download Presentation

WBC Pathology: Gen. Classification

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. WBC Pathology: Gen. Classification Leukopenia a. ineffective granulopoesis suppression of stem cells – aplastic An, drugs ineffective maturation - B12 def Congenital- Kostmann Syndrome b. increased destruction Ig-mediated injury peripheral utilization spleenic sequestration

  2. Proliferative states • Reactive • Neoplastic

  3. Reactive Proliferation of WBC in Smears • Leukocytosis neutrophilia – Bacterial infection, tissue necrosis lymphocytosis – chr infection, viral, immunologic eosinophilia – asthma, allergy, parasitic monocytosis – chr infection, collagen dis (SLE) 2. Leukemoidreaction • PBS changes: Neutrophils: toxic granules, Döhle bodies, shift to the left Reactive Lymphocytes – Atypical lymphocytes

  4. Myelogenous series

  5. Stab Döhle Body

  6. Toxic Granules Atypical Lymphocyte

  7. Reactive Proliferation of WBC in LN Acute Lymphadenitis  Reactive change 2o to microbiologic agents and their toxic prod • Foreign bodies or cell debris Chronic Lymphadenitis 1. Follicular hyperplasia i.e. Toxo, HIV  B- cell stimulation 2. Parafollicular/paracortical hyperplasia i.e. drugs, IM, vaccines  T cell stimulation 3. Sinus histiocytosis = Reticular hyperplasia seen in cancer

  8. Follicular Hyperplasia

  9. Chronic nonspecficlymphedenitis • Chronic immunological stimuli produce lesions in the lymph nodes • Follicular hyperplasia • Rheumatoid arthritis • HIV • Toxoplasmosis

  10. Paracortical hyperplasia • It is T cell mediated immune response • Acute viral infections • Like Infectivous mononucleosis • T cell region contain typical immunoblasts,activated T cell 3 to 4 times the normal round nuclei and several nucleous

  11. NEOPLASTIC PROLIFERATIONS • Lymphoid Neoplasms • Plasma cell Dyscracias • Myeloid Neoplasms • Histiocytosis

  12. Myeloid neoplasms • arise from stem cells • acute myelogenous leukemias, in which immature progenitor cells accumulate in the bone marrow; • chronic myeloproliferative disorders, in which inappropriately increased production of formed blood elements leads to elevated blood cell counts;

  13. myelodysplastic syndromes, which are characteristically associated with ineffective hematopoiesis and cytopenias • Histiocytic neoplasms represent proliferative lesions of histiocytes

  14. Leukemias (Acute and Chronic) • Malignant diseases of bone marrow stem cells • Risk factors • a. Chromosomal abnormalities • • Examples—Down syndrome, chromosome instability syndromes, type 1 neuro fibr • b. Ionizing radiation • • Example—nuclear plant explosion • c. Chemicals • Example—benz.ene for myeloid leukemia • d. Alkylating agents • • Particularly busulfan

  15. c. Chronic myeloproliferative diseases • • Example—polycythemia vera • f. Paroxysmal nocturnal hemoglobinuria • g. Cigarette smoking • h. Immimodeficieney diseases • • Example—Wiskott-Aldrich syndrome • 4. Age ranges for common leukemias

  16. Pathophysiology of Acute Leukemias • The principal pathogenetic problem in acute leukemia is a block in differentiation • accumulation of immature leukemic blasts in the bone marrow • suppress the function of normal hematopoietic stem cells • bone marrow failure

  17. NORMAL HEMATOPOESIS

  18. B cell Tumors 80% T cell Tumors 20% L Y M P H O I D T U M O R S

  19. REAL classif of Lymphoid Tumors 1. Precursor B cell (pre B cell) B lymphoblastic Leu (ALL) / lymphoma 2. Precursor T cell (pre T cell) T lymphoblastic Leu / Lymphoma 3. Peripheral B cell CLL , SLL Hairy cell Leu Burkitts Lymphoma Follicular lymphoma 4. Peripheral T cell or NK cell Adult T cell Lymphoma Anaplastic Large Cell Lymphoma Mycosis Fungoides / Sezary Syndrome 5. Hodgkins Lymphoma

  20. Cell Antigens in WBC

  21. B cell Tumors 80% T cell Tumors 20% CD1,CD2, CD5, CD7 CD10 CD19 CD10,CD19 CD23 CD5 L Y M P H O I D T U M O R S CD4 CD8 CD19, CD20 CD5, Ig CD 3 CD10,19,20 CD19,20

  22. Char. of lymphoid tumors • Mostly B-cells • Each type has its own clinical presentation • Associated with immune abnormalities • Most of them are Bcell origin • The daughter cell of malignant progenitor share the same antigenic receptor gene • Hodgkin lymphoma spread in orderly fashion.

  23. Acute lymphoblastic leukemia • Childhood ca • Origin • Immature B or T cell • Presence of Lymphoblast • Immune phenotype terminal deoxynucleotidyltransferaseTdT is a DNA polymerase present for immature B or T cell is positive in 95%

  24. The lymphoblasts express B cell marker CD10,19,20 • For T cell CD 2,5,7 • Hyperploidy more the 50 chromosomes • Chrmosomal aberrations in transcrption factors NOTCH1 N PAX5 which is necessary for B or T cell development • Mutations in these leads to development of ALL • Very good response to chemotherapy

  25. CLL also called as Small lymphocytic lymphoma also well differentiated lymphocytic lymphoma • Seen in adults also at the age of 60 yrs • I t is mature B cell or T cell origin • Common in Asia and Japan • Male to female 2:1

  26. Morhpology • The small lymphocytes of 6to 12 mircmt diameter with mixed with large lymphocytes • Irregular nuclei and scanty cytoplasm increased mitotic rate showing prominent proliferation center • Also SMUDGE cells bec the tumor lymphocyte are fragile give charcterstic of this app

  27. BM • Filled with tumor cells also red n white pulp of spllen occupied with tumor cells and hepatic portal system too involved • Immunephenotype • There is a chr deletion of 12q, 13q 11q and 17p • B cell marker CD 19 CD 20 and 23

  28. CF • Patients present with anemai,neutropenia and thrombocytopenia • There is hypogammaglobulonemia and prone to infections and asloautoantibodiesagaint red cells

  29. They transform to more aggressive form called • DIFFUSE LARGE B CELL LYMPHOMA called Richter syndrome PRO LYMPHOCYTIC LEUKEMIA • Which has poor prognosis

  30. Peripheral B cell Neoplasms • Small Lymphocytic Lymphoma/CLL • Follicular Lymphoma • Diffuse large B-Cell lymphoma • Burkitts Lymphoma • Extranodal Marginal zone lymphoma • Mantle Cell Lymphoma • Hairy cell Leukemia • Multiple Myeloma

  31. Histology: small cells mixed with “prolymphocytes” ~ proliferative centers

  32. Histo: small round lymphocytes with smudge cells

  33. FOLLICULAR LYMPHOMAS Most common type in the US (45%) Age: middle age; M ≈ F Chromosomal translocations involving BCL2 CF generalized painless lymphadenopathy w/ BM involvement. Extranodal spread is uncommon Prognosis: 7-9 ys, incurable Waxes & wanes, difficult to cure unaffected by Tx Progress to diffuse DLBL if with c-MYC Immunophenotype: + CD10, C19, CD 20 + Bcl-2 protein (90%)

  34. Chronic Lymphocytic Leukemia *Phenotypically & genotypically indistinguishable frSLL differing only in the degree of peripheral lymphocytosis WBC count: ↓ in SLL, ↑in CLL Dx: absolute lymphocyte count >4,000 IR: SLL 4% of NHL CLL Most common Leukemias of adults Chromosomal abn, age, sex, distribution & clinical picture, prognosis: same as SLL

  35. Bcl-2 protein Reactive Follicle Follicular Lymphoma

  36. Diffuse Large B cell Lymphoma (DLBCL) Age: elderly (median 60y/o); pedia (5%) CF Rapidly enlarging symptomatic mass at a single nodal or extranodal site Prognosis: Aggressive, rapidly fatal if untreated Chemotx complete remission in 60-80% Cytogenetics : bcl6 (30%);t(14:18) (10%) overexpression of BCL2 Immunophenotype: + CD19, CD20; + CD10,

  37. Morphology • Large cell with round or oval nuclei • Abudant cytoplasm

  38. Burkitt Lymphoma • This common in children young adults • # forms • African or endemic • Non endemic or american • Associated with HIV • Endemic present with mandible or maxillary mass with extranodal involvement like kidney,ovaries and adrenal glands

  39. The non endemic involves ileocecal junction and peritoneum • Morphology • Infiltration with intermediate lymphoid cells With multi lobe nucleoli and abundant cytoplasm • Benign macrophages giving app of STARRY SKY

  40. Immunephenotype • These B-cell tumors express surface IgM, κ or λ light chain, the pan-B-cell markers CD19 and CD20, and CD10 • Genotype • translocations involving the MYC gene on chromosome 8.

  41. Clinical Features • Present with mass in the extranodal are • Aggressive chemotherapy helps for the outcome of the lymphoma • Majoiryt of pt are cured.

  42. All endemic tumors are infected with EB virus

  43. Histology : Large cell size, multiple nucleoli, irregular nuclei, abundant cytoplasm

  44. Endemic pattern Sporadic pattern

  45. Starry sky pattern

More Related